GlassScriptPhysician profile
Kaejin Kim
NPI 1770551939
$4,440.21
in general payments reported to CMS, 2019-2025
21 companies · $409 in 2025
The $409 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $291 · 2021: $680 · 2022: $846 · 2023: $796 · 2024: $875 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,074 · Education: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,074.45 |
| Education | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,321.03 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $692.01 | 2019-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $478.63 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $314.25 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Corium, LLC | $237.68 | 2022-2025 | Azstarys |
| Sanofi Pasteur INC. | $215.10 | 2019-2025 | |
| Pfizer INC. | $207.23 | 2019-2025 | |
| Glaxosmithkline, LLC. | $177.19 | 2019-2025 | Bexsero, Pediarix, Menveo |
| Neos Therapeutics, LP | $150.03 | 2019-2020 | |
| Cranial Technologies, INC | $116.63 | 2019-2023 | Doc Band |
| Vertical Pharmaceuticals, LLC | $104.15 | 2019-2024 | Relexxii |
| Kaleo, INC. | $84.05 | 2019-2022 | |
| Genentech USA, INC. | $63.14 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $61.89 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.13 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $53.32 | 2025 | Jornay Pm |
| Sobi, INC | $37.33 | 2021-2023 | |
| Adlon Therapeutics L.P. | $21.98 | 2019 | |
| Baxter Healthcare | $17.46 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Mission Pharmacal Company | $15.02 | 2019 | |
| Greer Laboratories, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaejin Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.